PL2563763T3 - Kompozycje farmaceutyczne zawierające N-(4-(2-amino-3-chloropirydyn-4-yloksy)-3-fluorofenylo)-4-etoksy-1-(4-fluorofenylo)-2-okso- 1,2-dihydropirydyno-3-karboksyamid - Google Patents
Kompozycje farmaceutyczne zawierające N-(4-(2-amino-3-chloropirydyn-4-yloksy)-3-fluorofenylo)-4-etoksy-1-(4-fluorofenylo)-2-okso- 1,2-dihydropirydyno-3-karboksyamidInfo
- Publication number
- PL2563763T3 PL2563763T3 PL11717917T PL11717917T PL2563763T3 PL 2563763 T3 PL2563763 T3 PL 2563763T3 PL 11717917 T PL11717917 T PL 11717917T PL 11717917 T PL11717917 T PL 11717917T PL 2563763 T3 PL2563763 T3 PL 2563763T3
- Authority
- PL
- Poland
- Prior art keywords
- fluorophenyl
- chloropyridin
- dihydropyridine
- yloxy
- carboxamide
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32971010P | 2010-04-30 | 2010-04-30 | |
| PCT/US2011/034417 WO2011137274A1 (en) | 2010-04-30 | 2011-04-29 | Pharmaceutical compositions comprising n-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-l-(4-fluorophenyl)-2-oxo- 1,2-dihydropyridine-3 -carboxamide |
| EP11717917.6A EP2563763B1 (en) | 2010-04-30 | 2011-04-29 | Pharmaceutical compositions comprising n-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-l-(4-fluorophenyl)-2-oxo- 1,2-dihydropyridine-3 -carboxamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2563763T3 true PL2563763T3 (pl) | 2015-06-30 |
Family
ID=44209564
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11717917T PL2563763T3 (pl) | 2010-04-30 | 2011-04-29 | Kompozycje farmaceutyczne zawierające N-(4-(2-amino-3-chloropirydyn-4-yloksy)-3-fluorofenylo)-4-etoksy-1-(4-fluorofenylo)-2-okso- 1,2-dihydropirydyno-3-karboksyamid |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US8911785B2 (enExample) |
| EP (1) | EP2563763B1 (enExample) |
| JP (1) | JP5820874B2 (enExample) |
| KR (1) | KR101897302B1 (enExample) |
| CN (1) | CN102971296B (enExample) |
| DK (1) | DK2563763T3 (enExample) |
| ES (1) | ES2533075T3 (enExample) |
| HR (1) | HRP20150105T1 (enExample) |
| MY (1) | MY183769A (enExample) |
| PH (1) | PH12012502019A1 (enExample) |
| PL (1) | PL2563763T3 (enExample) |
| PT (1) | PT2563763E (enExample) |
| RS (1) | RS53790B1 (enExample) |
| SG (1) | SG184891A1 (enExample) |
| SI (1) | SI2563763T1 (enExample) |
| SM (1) | SMT201500069B (enExample) |
| WO (1) | WO2011137274A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013096858A1 (en) | 2011-12-22 | 2013-06-27 | Life Technologies Corporation | Cell culture media and methods |
| KR101545268B1 (ko) | 2015-02-05 | 2015-08-20 | 보령제약 주식회사 | 정제 및 이의 제조방법 |
| WO2016126012A1 (en) * | 2015-02-05 | 2016-08-11 | Boryung Pharmaceutical Co., Ltd | Tablet and method of preparing the same |
| EP3911320A4 (en) * | 2019-01-15 | 2022-11-30 | The Translational Genomics Research Institute | PHOSPHONATE CONJUGATES AND THEIR USES |
| US20230257364A1 (en) * | 2022-02-16 | 2023-08-17 | Cmg Pharmaceutical Co., Ltd. | Pyridazinone-based compounds as axl, c-met, and mer inhibitors and methods of use thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6214344B1 (en) | 1995-06-02 | 2001-04-10 | Genetech, Inc. | Hepatocyte growth factor receptor antagonists and uses thereof |
| CN1230883A (zh) * | 1996-09-24 | 1999-10-06 | 伊莱利利公司 | 包衣颗粒制剂 |
| US7459562B2 (en) | 2004-04-23 | 2008-12-02 | Bristol-Myers Squibb Company | Monocyclic heterocycles as kinase inhibitors |
| US20100016378A1 (en) * | 2005-04-28 | 2010-01-21 | Toshio Suzuki | Method of preventing dihydropyridine compound from degradation |
| TR200504775A1 (tr) | 2005-11-30 | 2007-10-22 | Esen Beki̇r | Kendinden metal takviyeli pvc pencere ve kapı profilleri |
| DE602006004694D1 (de) * | 2006-01-05 | 2009-02-26 | Teva Pharma | Feuchtgranulierungsmethode zur Herstellung pharmazeutischer Aripiprazolzusammensetzungen |
| WO2008058229A1 (en) * | 2006-11-08 | 2008-05-15 | Bristol-Myers Squibb Company | Pyridinone compounds |
| US20080260837A1 (en) * | 2007-04-20 | 2008-10-23 | Qpharma, L.L.C. | Physically stable aqueous suspensions of active pharmaceuticals |
| US8263652B2 (en) * | 2007-10-31 | 2012-09-11 | Sk Biopharmaceuticals Co., Ltd. | Stabilized pediatric suspension of carisbamate |
| JP5693239B2 (ja) | 2008-01-23 | 2015-04-01 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | ４−ピリジノン化合物および癌についてのその使用 |
-
2011
- 2011-04-29 CN CN201180032341.1A patent/CN102971296B/zh active Active
- 2011-04-29 KR KR1020127031220A patent/KR101897302B1/ko active Active
- 2011-04-29 US US13/643,561 patent/US8911785B2/en active Active
- 2011-04-29 EP EP11717917.6A patent/EP2563763B1/en active Active
- 2011-04-29 PL PL11717917T patent/PL2563763T3/pl unknown
- 2011-04-29 HR HRP20150105AT patent/HRP20150105T1/hr unknown
- 2011-04-29 WO PCT/US2011/034417 patent/WO2011137274A1/en not_active Ceased
- 2011-04-29 RS RS20150055A patent/RS53790B1/sr unknown
- 2011-04-29 PT PT11717917T patent/PT2563763E/pt unknown
- 2011-04-29 PH PH1/2012/502019A patent/PH12012502019A1/en unknown
- 2011-04-29 DK DK11717917.6T patent/DK2563763T3/en active
- 2011-04-29 SG SG2012076865A patent/SG184891A1/en unknown
- 2011-04-29 ES ES11717917.6T patent/ES2533075T3/es active Active
- 2011-04-29 JP JP2013508267A patent/JP5820874B2/ja active Active
- 2011-04-29 MY MYPI2012004708A patent/MY183769A/en unknown
- 2011-04-29 SI SI201130405T patent/SI2563763T1/sl unknown
-
2014
- 2014-09-15 US US14/486,139 patent/US9233948B2/en active Active
-
2015
- 2015-03-18 SM SM201500069T patent/SMT201500069B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PH12012502019A1 (en) | 2017-08-18 |
| SI2563763T1 (sl) | 2015-03-31 |
| MY183769A (en) | 2021-03-12 |
| WO2011137274A1 (en) | 2011-11-03 |
| PT2563763E (pt) | 2015-03-31 |
| AU2011245269A1 (en) | 2012-12-20 |
| SG184891A1 (en) | 2012-11-29 |
| US9233948B2 (en) | 2016-01-12 |
| ES2533075T3 (es) | 2015-04-07 |
| CN102971296A (zh) | 2013-03-13 |
| EP2563763A1 (en) | 2013-03-06 |
| RS53790B1 (sr) | 2015-06-30 |
| KR20130100237A (ko) | 2013-09-10 |
| US20130039989A1 (en) | 2013-02-14 |
| CN102971296B (zh) | 2015-11-25 |
| SMT201500069B (it) | 2015-05-05 |
| HK1179260A1 (en) | 2013-09-27 |
| EP2563763B1 (en) | 2014-12-31 |
| US8911785B2 (en) | 2014-12-16 |
| US20150065719A1 (en) | 2015-03-05 |
| HRP20150105T1 (hr) | 2015-03-13 |
| JP5820874B2 (ja) | 2015-11-24 |
| JP2013525455A (ja) | 2013-06-20 |
| DK2563763T3 (en) | 2015-04-07 |
| KR101897302B1 (ko) | 2018-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2566859A4 (en) | PICOLINAMIDE AND PYRIMIDINE-4-CARBOXAMIDE COMPOUNDS, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION THEREWITH | |
| TWI560183B (en) | Compounds and compositions for inhibiting the activity of abl1, abl2 and bcr-abl1 | |
| ZA201407341B (en) | Substituted hetero-bicyclic compounds, compositions and medicinal applications thereof | |
| IL242278A0 (en) | Compounds 4)-n-fluoro-2-methoxy-5-nitrophenyl)pyrimidine-2-converted amine and their salts | |
| IL233154A (en) | Compounds, pharmaceuticals containing them and their uses | |
| ZA201404733B (en) | Novel benzopyran compounds, compositions and uses thereof | |
| DK3284467T3 (da) | Nikotinholdige farmaceutiske sammensætninger | |
| IL220863A (en) | Oxazole derivatives of kinase inhibitors, medicinal preparations containing them and their uses | |
| IL233863A (en) | Pyridine derivatives, preparations containing them and their uses | |
| IL232035A (en) | These heterocyclic compounds, these compounds as a medicine and a pharmaceutical composition containing them | |
| BR112015002738A2 (pt) | composto , e , composição farmacêutica | |
| IL232914A0 (en) | New Azetidine histories, pharmaceutical preparations and their uses | |
| EP2827857A4 (en) | SPIROCYCLIC DIHYDRO-THIAZINE AND INHIBITORS OF BACE DIHYDRO-OXAZINE AND COMPOSITIONS AND USES THEREOF | |
| HUE037747T2 (hu) | Nanostrukturált aprepirant készítmények, eljárások azok elõállítására és az azokat tartalmazó gyógyászati készítmények | |
| BR112015003259A2 (pt) | composto, composição farmacêutica, e, composição de vacina. | |
| IL232917A (en) | Annals of 5 - (3-aminophenyl) -5-alkyl-6,5-dihydro-2h [4,1] oxazin-3-amine | |
| IL238060B (en) | 2-aminopyridine derivatives, their preparation and pharmaceutical compositions containing them | |
| IT1397694B1 (it) | Puntale per attacchi da sci-alpinismo. | |
| AP2012006232A0 (en) | New association between 4-ä3-ÄCIS-hexahydrocyclopentaÄcÜpyrrol-2(1H)-YLÜpropoxyübenzamide and an Acetylcholinesterase inhibitor, and pharmaceutical compositions containing it. | |
| IL237674A0 (en) | Herbicidal preparations containing aminopyralid and triclopyr | |
| EP2668186A1 (en) | Pharmaceutical composition comprising pyridone derivatives | |
| IL230484A (en) | "6- (n- (7-Chloro-1-Hydroxy-1, 3-Dihydrobenzo [c] [1,2] Oxaborol-5-Yl) - Methylbenzoforan-3 - Carbamamide and a Pharmaceutical Preparation | |
| SMT201500069B (it) | Composizioni farmaceutiche comprendenti n-(4-(2-ammino-3-cloropiridin-4-ilossi)-3-fluorofenil)-4-etossi-l-(4-fluorofenil)-2-osso-1,2-diidropiridin-3-carbossammide | |
| BR112014032501A2 (pt) | composto, e, composição farmacêutica. | |
| IL233682A0 (en) | Modified phenylazole derivatives, preparations containing them and their uses |